The following transactions relate to bond investments of Livermore Laboratories. The company$$s fiscal year ends on December $31.$ Livermore uses the straight$-$line method to determine interest.

$2024$

July $1$ Purchased $$34$ million of Bracecourt Corporation $10\%$ debentures, due in $20$ years $($June $30,2044),$ for $$33\mathrm{.}4$ million. Interest is payable on January $1$ and July $1$ of each year.

October $1$ Purchased $$48$ million of $12\%$ Framm Pharmaceuticals debentures, due May $31,2034,$ for $$51,248,000$ plus accrued interest. Interest is payable on June $1$ and December $1$ of each year.

December $1$ Received interest on the Framm bonds.

December $31$ Accrued interest.

$2025$

January $1$ Received interest on the Bracecourt bonds.

June $1$ Received interest on the Framm bonds.

July $1$ Received interest on the Bracecourt bonds.

September $1$ Sold $$24\mathrm{.}0$ million of the Framm bonds at $103$ plus accrued interest.

December $1$ Received interest on the remaining Framm bonds.

December $31$ Accrued interest.

$2026$

January $1$ Received interest on the Bracecourt bonds.

February $28$ Sold the remainder of the Framm bonds at $104$ plus accrued interest.

December $31$ Accrued interest.

Required:

Prepare the appropriate journal entries for these long$-$term bond investments.

By how much will Livermore Labs$$ earnings increase in each of the three years as a result of these investments? $($Ignore income taxes.$)$